Скажи НЕТ диабету. Готовый план действий. Патрик Холфорд

and risk of endometrial cancer: a prospective cohort study», Public Health Nutrition, 2005 oct; 8 (7): 912–9; and S.C. Larsson, et al., «Carbohydrate intake, glycemic index and glycemic load in relation to risk of endometrial cancer: a prospective study of Swedish women», International Journal of Cancer, 2007 Mar; 120 (5): 1103–7

      31

      A. Tavani, et al., «Consumption of sweet foods and breast cancer risk in Italy», Annals of Oncology, 2005 oct; 17 (2): 341–5

      32

      M. Vanhala, et al., «Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study», Acta Psychiatrica Scandinavica, 2009 Feb; 119: 137–142

      33

      L. Pulkki-Raback, et al., «Depressive Symptoms and the Metabolic Syndrome in Childhood and adulthood: a Prospective Cohort Study», Health Psychology, 2009 Jan; 28 (1): 108–116

      34

      A. Pan, et al., «Bidirectional association between depression and type-2 diabetes mellitus in women», Archives of Internal Medicine, 2010; 170(21): 1884–91

      35

      A. Pan, et al., «Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: Findings from the Nutrition and Health of aging Population in China Study», Journal of Affective Disorders, 2008 July; 109 (1): 75–82

      36

      R. S. McIntyre, et al., «Should depressive syndromes be reclassified as “metabolic syndrome type II”?», Annals of Clinical Psychiatry, 2007 oct – Dec; 19 (4): 257–64

      37

      H. Viinamäki, et al., «Association of depressive symptoms and metabolic syndrome in men», Acta Psychiatrica Scandinavica, 2009 July; 120 (1): 23–9

      38

      L. Richardson, et al., «Longitudinal effects of depression on glycemic control in veterans with type-2 diabetes», General Hospital Psychiatry, 2008 Nov; 30 (6): 509–14

      39

      R. S. McIntyre, et al. «Should depressive syndromes be reclassified as “metabolic syndrome type II”?», Annals of Clinical Psychiatry, 2007 oct – Dec; 19 (4): 257–64

      40

      T. Matsuzaki, et al., «Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study», Neurology, 2010 aug; 75 (9): 764–70

      41

      K. Yaffe, «The metabolic syndrome and development of cognitive impairment among older women», Archives of Neurology, 2009 Mar; 66 (3): 324–8

      42

      A. M. Kanaya, «Total and Regional adiposity and Cognitive Change in older adults: the Health, aging, and Body Composition study», Archives of Neurology 2009 March; 66 (3): 329–335

      43

      A. Kareinen, et al., «Cardiovascular Risk Factors associated With insulin Resistance Cluster in Families With Early-onset Coronary Heart Disease», Arteriosclerosis Thrombosis and Vascular Biology, 2001; 21; 1346–1352; см. также K. Yaffe, et al., «The Metabolic Syndrome and Development of Cognitive impairment among older Women», Archives of Neurology, 2009; 66 (3): 324–328; см. также S. Craft, «The Role of Metabolic Disorders in alzheimer Disease and Vascular Dementia: two Roads Converged», Archives of Neurology, 2009; 66 (3): 300–305

      44

      I. Kyrou and C. Tsigos, «Chronic stress, visceral obesity and gonadal dysfunction», Hormones, 2008; 7 (4): 287–293

      45

      J. Vrbikova, et al., «Metabolic syndrome in adolescents with polycystic ovary syndrome», Gynecological Endocrinology, 2010 Sep; (Только в электронном виде)

      46

      S. Kayaniyil, et al., «Association of 25 (OH)D and PTH with metabolic syndrome and its traditional and nontraditional components», Journal of Clinical Endocrinology and Metabolism, 2010 oct 27 (Только в электронном виде)

      47

      A. H. Colagar, et al., «Zinc levels in seminal plasma are associated with sperm quality in fertile and infertile», Nutrition Research, 2009 Feb; 29 (2): 82–88; и M. Akmal, et al., «Improvement in human semen quality after oral supplementation of vitamin C», Journal of Medicinal Food, 2006 Sep; 9 (3):440–2; и A. Khosrowbeygia и N. Zarghami, http://www.plefa.com/article/S0952-3278 %2807 %2900103-2/abstract – aff2, «Fatty acid composition of human spermatozoa and seminal plasma levels of oxidative stress biomarkers in subfertile males», Prostaglandins, Leukotrienes and Essential Fatty Acids, 2007 aug; 77 (2): 117–21

      48

      S. Hexeberg and F. Lindberg, «Insulin using woman with type-2 diabetes and weight problems», Medisin Og Vitenskap Noe a lare av Tidsskr Nor Legeforen, 2008; 128: 443–5

      49

      G. Li, et al., «The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study», Lancet, 2008 May; 371 (9626): 1783–9

      50

      D. R. Jacobs, et al., «Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study», American Journal of Clinical Nutrition, 2009 Feb; 89: 509–17

      51

      K. J. Copell, et al., «Nutritional intervention in patients with type-2 diabetes who are hyperglycaemic despite optimised drug treatment: Lifestyle over and above Drugs in Diabetes (LOADD) study: Randomised controlled trial», British Medical Journal, 2010 July; 341: c3337 (ISSN: 1468–5833)

      52

      J. Lindstrom, et al., «The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity», Diabetes Care, 2003; 26 (12): 3230–6

      53

      W. C. Knowler, «Reduction in the incidence of type-2 diabetes with lifestyle intervention or metformin», New England Journal of Medicine, 2002 Feb 7; 346 (6): 393–403

      54

      T. Wu, et al., «Associations of serum C-reactive protein with fasting insulin, glucose and glycosylated haemoglobin», American Journal of Epidemiology, 2002; 155: 65–71

      55

      W. C. knowler, et al., «Diabetes in the Pima Indians: incidence, risk factors and pathogenesis», Diabetes and Metabolism Review, 1990; 6: 1–27

      56

      Dr. Charles Clarke and Maureen Clarke, Diabetes Revolution, Vermillion, 2008

      57

      S. Eyre, “Overlapping genetic susceptibility variants between three autoimmune disorders: Rheumatoid arthritis, type-1 diabetes